Neil Steven

Dr.

Accepting PhD Students

PhD projects

Neil Steven is a consultant treating people with cancer. He uses chemotherapy to treat people with colorectal carcinoma: to prevent recurrence after they have had surgery or to treat advanced metastatic disease. He uses systemic therapy for people with advanced aggressive skin cancers, mostly melanoma or Merkel cell carcinoma. In both settings, he works as part of a multidisciplinary team that highlights care for the patient and that personalises treatment where possible using biological markers of the disease. He seeks opportunities for patients to enter trials, including those set up and run by charities and the UK National Institute for Health Research and those run by the pharmaceutical industry.

Dr Steven is a clinical trialist with a particular interest in immunotherapy and in trials moving modalities from the laboratory to the clinic. He leads the strategic overview of the early phase trials portfolio for solid cancers in the CRCTU and on behalf of the Birmingham Experimental Cancer Medicine Centre.

1993 …2022

Research activity per year

Network

Benjamin Fisher

Person: Academic

Rachel Hoare

Person: Professional Services

Sheila Greenfield

Person: Academic

Sarah Damery

Person: Academic

Benjamin Willcox

Person: Academic

Sarah Berhane

Person: Academic

Kai Toellner

Person: Academic

Ilfita Sahbudin

Person: Academic

Andrew Filer

Person: Academic

Leila Khoja

Person: Honorary

Aimee Jackson

Person: Academic

Paul Moss

Person: Academic

Julie Mason

  • Pharmacy - Assistant Professor in Clinical Pharmacy

Person: Academic

Janet Jones

Person: Academic

Sarah Pirrie

Person: Academic

Punith Kempegowda

Person: Academic

Chris Tselepis

Person: Academic

R Grieve

  • University Hospitals Coventry and Warwickshire NHS Trust

External person

David J. Blackbourn

  • University of Surrey

External person

Jerry R Marsden

  • Queen Elizabeth Hospital Birmingham

External person

Christian Ottensmeier

  • University of Southampton

External person

Anthony Williams

  • University of Southampton
  • Birmingham Women's Hospital NHS Foundation Trust

External person

Jennifer S Pascoe

  • Queen Elizabeth Hospital Birmingham

External person

Anna Olsson-Brown

  • The Clatterbridge Cancer Centre NHS Foundation Trust
  • University of Liverpool

External person

E Marshall

  • Gloucestershire Hospitals NHS Foundation Trust

External person

Tim Waterboer

  • DKFZ (German Cancer Research Centre)

External person

Elisabeth Hodges

  • University of Southampton

External person

Dean Naisbitt

  • University of Liverpool

External person

L. Sherman

  • GlaxoSmithKline

External person

A Chapman

  • University of Southampton

External person

J.p. Mohr

  • Elbekliniken

External person

G. Eric Blair

  • University of Leeds

External person

Uwais Mufti

  • Imperial College London

External person

Andrew Gibson

  • John Radcliffe Hospital
  • Murdoch University

External person

Yulan Wang

  • Nanyang Technological University

External person

U. Trefzer

  • Charité-Universitätsmedizin

External person

Melanie Harvey

  • University of Southampton

External person

Hussein Abdul-Sada

  • University of Leeds

External person

Stephanie Harrison

  • University of Leeds

External person

P. Wolter

  • Leuven Cancer Institute

External person

S Naylor

  • Shadow Robot Ltd.

External person

A Young

  • Royal Free London NHS Foundation Trust
  • University of Edinburgh

External person

Claude Chan

  • University of Southampton

External person

Laura M. Knight

  • University of Leeds

External person

Claus Garbe

  • Eberhard Karls University of Tübingen,

External person

MM Amonkar

  • GlaxoSmithKline
  • GlaxoSmithKline, USA

External person

J. C. Hassel

  • Heidelberg University Hospital

External person

Xiaoli Meng

  • University of Liverpool

External person

Laifeng Ding

  • Wuhan Institute of Physics and Mathematics Chinese Academy of Sciences

External person

Silvia Ottaviani

  • Imperial College London

External person

Sophie Grice

  • University of Liverpool

External person

Florence Joly

  • GINECO-Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens

External person

Gabriele Stakaityte

  • University of Leeds

External person

R. Dummer

  • University Hospital Zürich

External person

Leandro Castellano

  • Imperial College London

External person

Devmini Moonamale

  • Imperial College London

External person

Martin Glennie

  • University of Southampton

External person

Ceri Edwards

  • Cancer Research UK

External person

Francesco Mauri

  • Imperial College London

External person

Michael J Seckl

  • Imperial College London

External person

Ferdousi Chowdhury

  • University of Southampton

External person

David J Pinato

  • Imperial College London

External person

Miriam Molina-Arcas

  • The Francis Crick Institute

External person

Rajat Roy

  • National Metallurgical Laboratory
  • Imperial College London

External person

Paul Kerr

  • University of Southampton

External person

Joel M. Abrahams

  • Imperial College London

External person

Anna Smith

  • University of Southampton

External person

J Mark Skehel

  • Medical Research Council Technology

External person

Kevin Harrington

  • Institute for Cancer Research
  • Royal Marsden NHS Foundation Trust

External person

Yifang Gao

  • University of Southampton

External person

Tom Geldart

  • University of Southampton

External person

Olivier E. Pardo

  • Imperial College London

External person

Maruf M.U. Ali

  • Imperial College London

External person

Mauricio Barahona

  • Imperial College London

External person

D McDonald

  • University of Stirling

External person

P Simmonds

  • Royal South Hampshire Hospital

External person

Dan Leibovici

  • Kaplan Medical Center

External person

Mathias Winkler

  • Imperial College Healthcare NHS Trust

External person

John Post

  • University of Dundee

External person

C. Robert

  • Institut Gustave-Roussy

External person

David Hrouda

  • Imperial College Healthcare NHS Trust

External person

Filippo Prischi

  • University of Essex
  • Imperial College London

External person

Sophia N. Yaliraki

  • Imperial College London

External person

Romain Lara

  • Imperial College London
  • AstraZeneca
  • Spanish Research Council (IDÆA-CSIC)

External person

David A. Griffiths

  • University of Leeds

External person

A Rutten

  • Sint-Augustinus

External person

Peter W M Johnson

  • University of Southampton

External person

Christopher J. Moore

  • University of Cambridge
  • The Francis Crick Institute

External person

Adrian Whitehouse

  • University of Leeds

External person

Lucksamon Thamlikitkul

  • Imperial College London
  • Mahidol University

External person

Shay Golan

  • Rabin Medical Center Israel

External person

Gareth J Howell

  • University of Leeds

External person

Jennifer Pascoe

  • University Hospital Birmingham NHS Foundation Trust

External person

K Patel

  • GlaxoSmithKline

External person

M. Milhem

  • University of Iowa

External person

Philip Cohen

  • University of Dundee

External person

Stephen L Chan

  • Nottingham University Hospitals NHS Trust

External person

Stelios Chrysostomou

  • Imperial College London

External person

Robert Peach

  • Imperial College London
  • University of Würzburg

External person

Kathryn L. Chapman

  • Imperial College London
  • Domainex Ltd.

External person

Ruth Challis

  • University of Southampton

External person

Andrew Macdonald

  • University of Leeds
  • University of Manchester

External person

Jennifer J. Wood

  • University of Leeds

External person

Munir Pirmohamed

  • University of Liverpool

External person

Ankit Jain

  • Queen Elizabeth Hospital Birmingham

External person

Julian Downward

  • The Francis Crick Institute

External person

P. Rutkowski

  • Institute of Oncology, Warsaw

External person

Margaret Ashton-Key

  • University of Southampton

External person

G. Ullenhag

  • University of Uppsala

External person

R Huddart

  • Urology Unit

External person

N Boota

  • Nottingham Clinical Trials Unit

External person

K. Grotzinger

  • GlaxoSmithKline

External person

David R. Klug

  • Imperial College London

External person

F. S. Wu

  • GlaxoSmithKline

External person

L. V. Demidov

  • Russian Academy of Medical Sciences

External person

R Midgley

  • Shell Aviation Ltd
  • Shell Centre

External person

D Schadendorf

  • University Hospital Essen

External person

Vered Bar

  • Curesponse

External person

David Hancock

  • The Francis Crick Institute

External person

Alison Tutt

  • University of Southampton

External person

M Casey

  • GlaxoSmithKline

External person

Georgios Giamas

  • University of Sussex

External person

C. Lefeuvre-Plesse

  • Centre Eugène Marquis

External person

Michael H Cullen

  • Queen Elizabeth Hospital Birmingham

External person